28144096|t|Burden of cervical cancer and role of screening in India
28144096|a|Cervical cancer is a major cause of cancer mortality in women and more than a quarter of its global burden is contributed by developing countries. In India, in spite of alarmingly high figures, there is no nationwide government-sponsored screening program. This study was conducted to assess the burden of cervical cancer in India and review the performance characteristics of available cervical cancer screening tools, so as to provide evidence -based recommendations for application of most practically suited screening test to be used in resource -poor field settings. MEDLINE and Web of Science electronic database were searched from January 1990 to December 2015, using the keywords such as " cervical cancer ", " screening ", " early detection ", " cervical cytology " and " visual inspection ", and their corresponding MeSH terms in combination with Boolean operators "OR, AND." Two authors independently selected studies that are published in English and conducted in India. A total of 11 studies were found to be relevant and eligible to be included in the present study. In India, cervical cancer contributes to approximately 6-29% of all cancers in women. The age-adjusted incidence rate of cervical cancer varies widely among registries; highest is 23.07/100,000 in Mizoram state and the lowest is 4.91/100,000 in Dibrugarh district. The pooled estimates of sensitivity and specificity of visual inspection with acetic acid (VIA), magnified VIA, visual inspection with Lugol's iodine (VILI), cytology (Pap smear), and human papillomavirus DNA were found to be 67.65% and 84.32%, 65.36% and 85.76%, 78.27% and 87.10%, 62.11% and 93.51%, and 77.81% and 91.54%, respectively. In developing countries because of lack of necessary infrastructure and quality control, high-quality cytology screening may not be feasible for wide-scale implementation. Hence, cervical cancer screening program based on visual screening test such as VIA / VILI should be adopted as an integral part of primary health-care setup in resource - poor countries like India.
28144096	0	6	Burden	T078	C2828008
28144096	10	25	cervical cancer	T191	C4048328
28144096	38	47	screening	T058	C1710032
28144096	51	56	India	T083	C0021201
28144096	57	72	Cervical cancer	T191	C4048328
28144096	93	109	cancer mortality	T081	C1516192
28144096	113	118	women	T098	C0043210
28144096	135	142	quarter	T081	C2825406
28144096	150	156	global	T080	C2348867
28144096	157	163	burden	T078	C2828008
28144096	167	178	contributed	T052	C1880177
28144096	182	202	developing countries	T080	C0011750
28144096	207	212	India	T083	C0021201
28144096	274	312	government-sponsored screening program	T064	C0018109
28144096	319	324	study	T062	C2603343
28144096	329	338	conducted	T169	C0205245
28144096	342	348	assess	T052	C1516048
28144096	353	359	burden	T078	C2828008
28144096	363	378	cervical cancer	T191	C4048328
28144096	382	387	India	T083	C0021201
28144096	392	398	review	T169	C0699752
28144096	403	414	performance	T052	C1882330
28144096	415	430	characteristics	T080	C1521970
28144096	444	459	cervical cancer	T191	C4048328
28144096	460	469	screening	T058	C1710032
28144096	486	493	provide	T052	C1999230
28144096	494	502	evidence	T078	C3887511
28144096	510	525	recommendations	T078	C0034866
28144096	569	583	screening test	T060	C2717746
28144096	598	606	resource	T078	C0035201
28144096	629	636	MEDLINE	T170	C0025141
28144096	641	675	Web of Science electronic database	T170	C3841595
28144096	681	689	searched	T052	C1706202
28144096	695	702	January	T080	C3829466
28144096	711	719	December	T080	C3830550
28144096	736	744	keywords	T170	C1708608
28144096	755	770	cervical cancer	T191	C4048328
28144096	776	785	screening	T060	C2717746
28144096	791	806	early detection	T060	C0596473
28144096	812	829	cervical cytology	T059	C0856201
28144096	838	855	visual inspection	T058	C3669138
28144096	883	893	MeSH terms	T170	C1135584
28144096	897	908	combination	T080	C0205195
28144096	914	931	Boolean operators	T169	C1881439
28144096	947	954	authors	T097	C3812881
28144096	969	977	selected	T052	C1707391
28144096	978	985	studies	T062	C2603343
28144096	995	1004	published	T170	C1704324
28144096	1008	1015	English	T171	C0376245
28144096	1020	1029	conducted	T169	C0205245
28144096	1033	1038	India	T083	C0021201
28144096	1042	1047	total	T080	C0439810
28144096	1054	1061	studies	T062	C2603343
28144096	1067	1072	found	T033	C0150312
28144096	1079	1087	relevant	T080	C2347946
28144096	1092	1100	eligible	T080	C1548635
28144096	1107	1115	included	T169	C0332257
28144096	1123	1130	present	T033	C0150312
28144096	1131	1136	study	T062	C2603343
28144096	1141	1146	India	T083	C0021201
28144096	1148	1163	cervical cancer	T191	C4048328
28144096	1164	1175	contributes	T052	C1880177
28144096	1179	1192	approximately	T080	C0332232
28144096	1206	1213	cancers	T191	C0006826
28144096	1217	1222	women	T098	C0043210
28144096	1228	1255	age-adjusted incidence rate	T081	C1706747
28144096	1259	1274	cervical cancer	T191	C4048328
28144096	1295	1305	registries	T170	C0034975
28144096	1307	1314	highest	T080	C1522410
28144096	1335	1348	Mizoram state	UnknownType	C0681784
28144096	1357	1363	lowest	T080	C1708760
28144096	1383	1401	Dibrugarh district	UnknownType	C0681784
28144096	1414	1423	estimates	T081	C0750572
28144096	1427	1438	sensitivity	T081	C0036667
28144096	1443	1454	specificity	T081	C0037791
28144096	1458	1492	visual inspection with acetic acid	T060	C0430022
28144096	1494	1497	VIA	T060	C0430022
28144096	1500	1513	magnified VIA	T060	C0430022
28144096	1515	1552	visual inspection with Lugol's iodine	T060	C1519194
28144096	1554	1558	VILI	T060	C1519194
28144096	1561	1569	cytology	T059	C1305671
28144096	1571	1580	Pap smear	T060	C0079104
28144096	1587	1611	human papillomavirus DNA	T059	C2985459
28144096	1745	1765	developing countries	T080	C0011750
28144096	1777	1781	lack	T080	C0332268
28144096	1795	1809	infrastructure	T185	C1998546
28144096	1814	1829	quality control	T169	C0034378
28144096	1831	1843	high-quality	T080	C0332306
28144096	1844	1862	cytology screening	T060	C0199230
28144096	1898	1912	implementation	T052	C1708476
28144096	1921	1936	cervical cancer	T191	C4048328
28144096	1937	1946	screening	T058	C1710032
28144096	1947	1954	program	T169	C3484370
28144096	1964	1985	visual screening test	T060	C2717746
28144096	1994	1997	VIA	T060	C0430022
28144096	2000	2004	VILI	T060	C1519194
28144096	2054	2071	health-care setup	T058	C0086388
28144096	2075	2083	resource	T078	C0035201
28144096	2086	2090	poor	T080	C2700379
28144096	2091	2100	countries	T083	C0454664
28144096	2106	2111	India	T083	C0021201